TrialInternational journal of clinical oncology2021

Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Jun Taguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.